Increase efficiencies and productivity by automating core reporting tasks for medical writing.
Automate core regulatory report documents across the CTD pyramid and dramatically accelerate submission timelines.
Yseop’s first CMC-focused offering automates the Quality Overall Summary (Module 2.3), a central component of regulatory submissions that pulls structured insights from Module 3.2.
Yseop Expands into CMC: Redefining Regulatory Automation Beyond Clinical Read More »
The FDA has begun using generative AI to review drug submissions, signaling a major shift in regulatory review. Learn how this impacts pharma teams and what it takes to make your content AI-ready.
The AI landscape is evolving rapidly. While pre-configured workflows have powered automation for years, the next frontier lies in intelligent AI agents—systems that can plan, adapt and execute tasks dynamically rather than following static scripts.
From Workflows to AI Agents: The Next Evolution in Automation Read More »
Milestones and partnerships showcase the company’s role as a trusted partner for AI-driven innovation in the pharmaceutical industry.
Yseop Kicks Off 2025 by Strengthening Its Leadership in Generative AI for Life Sciences Read More »
Yseop’s latest whitepaper, “Harness the Power of Generative AI in Pharma,” is now live! Discover how Generative AI is transforming drug discovery, accelerating clinical trials, and streamlining regulatory submissions. Download now.
Strategic Choices for AI in Biopharma: Partnering for Effective Implementation Read More »
Yseop’s latest whitepaper, “Harness the Power of Generative AI in Pharma,” is now live!
Harness the Power of Generative AI in Pharma: A Sneak Peek at Our Whitepaper Read More »
Yseop’s latest whitepaper, “Harness the Power of Generative AI in Pharma,” is now live! Discover how Generative AI is transforming drug discovery, accelerating clinical trials, and streamlining regulatory submissions. Download now.
Unlock the Future of Pharma with Generative AI: Download GenAI Whitepaper Read More »
Gartner’s analysis indicates a significant shift in generative AI, moving from rapid growth to stabilization and incremental improvements. At Yseop, we embrace this evolution, continuously enhancing our platform to deliver reliable and efficient AI solutions. Learn how we capitalize on the current phase to drive the future of AI-driven content generation.
Navigating the Maturity of Generative AI: Yseop’s Approach to Continuous Improvement Read More »
In the ever-evolving pharmaceutical landscape, the integration of artificial intelligence (AI) in clinical trials is a game-changer, enhancing efficiency and effectiveness. By exploring the advantages of AI in late-stage drug development, we reveal how AI optimizes clinical trials, streamlines data collection, and improves patient recruitment and retention. Dive in to discover how AI can transform your drug development process and position your organization at the forefront of innovation.
The Transformative Power of AI in Late-Stage Drug Development Read More »
Discover how Yseop, a French start-up, teams up with AWS to revolutionize clinical trials using AI for faster drug development.
This French start-up wants to use AI to develop new medicines more quickly Read More »